Trial record 170 of 350 for:
Gastrointestinal Stromal Tumors
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03556384 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 14, 2018
Last Update Posted : August 31, 2023
|
Sponsor:
Adam Burgoyne, MD, PhD
Information provided by (Responsible Party):
Adam Burgoyne, MD, PhD, University of California, San Diego
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2024 |
| Estimated Study Completion Date : | June 2025 |